Regression of Hodgkin Lymphoma in Response to Antiviral Therapy for Hepatitis C Virus Infection

被引：26

作者：

Takahashi, Ken ^{[1
]}

Nishida, Naoshi ^{[1
]}

Kawabata, Hiroshi ^{[2
]}

Haga, Hironori ^{[3
]}

Chiba, Tsutomu ^{[1
]}

机构：

[1] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto 6068501, Japan

[2] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto 6068501, Japan

[3] Kyoto Univ Hosp, Dept Diagnost Pathol, Kyoto, Japan

来源：

INTERNAL MEDICINE | 2012年 / 51卷 / 19期

关键词：

hepatitis C virus; Hodgkin lymphoma; interferon; B-CELL LYMPHOMA; ZONE LYMPHOMAS; INTERFERON; BIOLOGY;

D O I：

10.2169/internalmedicine.51.8404

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Links between hepatitis C virus (HCV) infection and several non-Hodgkin lymphomas have been suggested by epidemiological studies. We herein report the first documented case of a patient with HCV-associated Hodgkin lymphoma who showed a marked regression following interferon-based antiviral therapy. This unique case extends the spectrum of HCV-associated malignant lymphomas, confirms the efficacy of antiviral therapy for this rare extrahepatic manifestation and provides valuable clues for achieving a better understanding of lymphomagenesis in HCV.

引用

页码：2745 / 2747

页数：3

共 50 条

[41] Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection
Su, Tung-Hung
Liu, Chun-Jen
Tseng, Tai-Chung
Chou, Shih-Wan
Liu, Chen-Hua
Yang, Hung-Chih
Wu, Shang-Ju
Chen, Pei-Jer
Chen, Ding-Shinn
Chen, Chi-Ling
Kao, Jia-Horng
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (03) : 331 - 339
[42] Hepatitis C virus and intracellular antiviral response
Lee, Jiyoung
Ou, Jing-Hsiung J.
CURRENT OPINION IN VIROLOGY, 2022, 52 : 244 - 249
[43] Hepatitis C virus and non-Hodgkin's lymphoma: biology, epidemiology and therapy
Pozzato, Gabriele
Zorat, Francesca
Bonetto, Stefania
Mazzaro, Cesare
ONCOLOGY REVIEWS, 2011, 5 (04) : 249 - 260
[44] The impact of prior hepatitis B virus (HBV) infection on liver histology and the response to antiviral therapy in chronic hepatitis C.
Myers, RP
Thibault, V
Poynard, T
HEPATOLOGY, 2002, 36 (04) : 587A - 587A
[45] Antiviral therapy and resistance with hepatitis B virus infection
Hans L Tillmann
World Journal of Gastroenterology, 2007, (01) : 125 - 140
[46] Antiviral therapy and resistance with hepatitis B virus infection
Tillmann, Hans L.
WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (01) : 125 - 140
[47] Sustained Virologic Response to Antiviral Therapy for Chronic Hepatitis C Virus Infection: A Cure and So Much More
Pearlman, Brian L.
Traub, Nomi
CLINICAL INFECTIOUS DISEASES, 2011, 52 (07) : 889 - 900
[48] Significance of antiviral therapy and CTL-mediated immune response in containing hepatitis B and C virus infection
Njagarah, John B. H.
Nyabadza, Farai
Kgosimore, Moatlhodi
Hui, Cang
APPLIED MATHEMATICS AND COMPUTATION, 2021, 397
[49] Racial Differences in Response to Interferon-Based Antiviral Therapy for Hepatitis C Virus Infection: A Hardwiring Issue?
Tai, Andrew W.
Chung, Raymond T.
JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (08): : 1101 - 1103
[50] Monitoring response to antiviral therapy for patients with chronic hepatitis C virus infection by a core-antigen assay
Rebucci, C
Cerino, A
Cividini, A
Timo, L
Furione, M
Mondelli, MU
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (08) : 3881 - 3884

← 1 2 3 4 5 →